{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:52:30Z","timestamp":1776149550687,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-40323-x","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T13:03:52Z","timestamp":1772715832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decreased potential for lymphatic vessel generation is a hallmark of early diagnosed arterial hypertension and can be reversed by treatment with angiotensin converting enzyme inhibitors"],"prefix":"10.1038","volume":"16","author":[{"given":"Mateusz","family":"Gliwi\u0144ski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Koli\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzanna","family":"Urban-W\u00f3jciuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Zieli\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Piekarska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Fra\u015bciszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"\u017by\u0142ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafa\u0142","family":"P\u0119ksa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Karczewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gra\u017cyna","family":"Peszy\u0144ska-Sularz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartosz","family":"Trzeciak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Molisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Gutknecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Reiwer-Gostomska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Pietrzykowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Iwaszkiewicz-Grze\u015b","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Biernat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Glasner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leopold","family":"Glasner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Chru\u015bciel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Trzonkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia Maria","family":"Marek-Trzonkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"issue":"10304","key":"40323_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"(NCD-RisC)","year":"2021","unstructured":"(NCD-RisC). N.R.F.C. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 398 (10304), 957\u2013980 (2021).","journal-title":"Lancet"},{"key":"40323_CR2","doi-asserted-by":"publisher","first-page":"18014","DOI":"10.1038\/nrdp.2018.14","volume":"4","author":"S Oparil","year":"2018","unstructured":"Oparil, S. et al. Hypertension Nat. Rev. Dis. Primers 4: 18014 (2018).","journal-title":"Hypertension Nat. Rev. Dis. Primers"},{"issue":"4","key":"40323_CR3","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1161\/01.HYP.33.4.998","volume":"33","author":"TF Antonios","year":"1999","unstructured":"Antonios, T. F. et al. Structural skin capillary rarefaction in essential hypertension. Hypertension 33 (4), 998\u20131001 (1999).","journal-title":"Hypertension"},{"issue":"12","key":"40323_CR4","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/jhh.2009.63","volume":"23","author":"R Humar","year":"2009","unstructured":"Humar, R., Zimmerli, L. & Battegay, E. Angiogenesis and hypertension: An update. J. Hum. Hypertens. 23(12), 773\u201382 (2009).","journal-title":"J. Hum. Hypertens."},{"issue":"5","key":"40323_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nm.1960","volume":"15","author":"A Machnik","year":"2009","unstructured":"Machnik, A. et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat. Med. 15 (5), 545\u2013552 (2009).","journal-title":"Nat. Med."},{"issue":"3","key":"40323_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/HYPERTENSIONAHA.109.143339","volume":"55","author":"A Machnik","year":"2010","unstructured":"Machnik, A. et al. Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein\/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats. Hypertension 55 (3), 755\u2013761 (2010).","journal-title":"Hypertension"},{"issue":"2","key":"40323_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.clim.2010.07.007","volume":"137","author":"N Marek","year":"2010","unstructured":"Marek, N. et al. Increased spontaneous production of VEGF by CD4\u2009+\u2009T cells in type 1 diabetes. Clin. Immunol. 137(2), 261\u201370 (2010).","journal-title":"Clin. Immunol."},{"issue":"15","key":"40323_CR8","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.107.694778","volume":"116","author":"J Hur","year":"2007","unstructured":"Hur, J. et al. Identification of a novel role of T cells in postnatal vasculogenesis: Characterization of endothelial progenitor cell colonies. Circulation 116(15), 1671\u201382 (2007).","journal-title":"Circulation"},{"key":"40323_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/2045-824X-3-11","volume":"3","author":"PC Rae","year":"2011","unstructured":"Rae, P. C. et al. Angiogenic potential of endothelial progenitor cells and embryonic stem cells. Vasc. Cell 3, 11 (2011).","journal-title":"Vasc. Cell"},{"issue":"7","key":"40323_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1056\/NEJMoa022287","volume":"348","author":"JM Hill","year":"2003","unstructured":"Hill, J. M. et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348(7), 593\u2013600 (2003).","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"40323_CR11","doi-asserted-by":"publisher","first-page":"e0189535","DOI":"10.1371\/journal.pone.0189535","volume":"12","author":"SD Silva","year":"2017","unstructured":"Silva, S. D. et al. Temporal changes in cardiac oxidative stress, inflammation and remodeling induced by exercise in hypertension: Role for local angiotensin II reduction. PLoS One 12(12), e0189535 (2017).","journal-title":"PLoS One"},{"issue":"3","key":"40323_CR12","first-page":"181","volume":"17","author":"J My\u015bliwska","year":"2006","unstructured":"My\u015bliwska, J. et al. Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries. Eur. Cytokine Netw. 17 (3), 181\u2013188 (2006).","journal-title":"Eur. Cytokine Netw."},{"issue":"1","key":"40323_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.diabres.2007.07.011","volume":"79","author":"M My\u015bliwiec","year":"2008","unstructured":"My\u015bliwiec, M. et al. The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy. Diabetes Res. Clin. Pract. 79(1), 141\u20136 (2008).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"11","key":"40323_CR14","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/cvr\/cvy112","volume":"114","author":"R Loperena","year":"2018","unstructured":"Loperena, R. et al. Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: Roles of STAT3, interleukin 6 and hydrogen peroxide. Cardiovasc. Res. 114(11), 1547\u20131563 (2018).","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"40323_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/sj.jhh.1001845","volume":"19","author":"G V\u00e1zquez-Oliva","year":"2005","unstructured":"V\u00e1zquez-Oliva, G. et al. Lowering of blood pressure leads to decreased circulating interleukin-6 in hypertensive subjects. J. Hum. Hypertens. 19(6), 457\u201362 (2005).","journal-title":"J. Hum. Hypertens."},{"issue":"3","key":"40323_CR16","doi-asserted-by":"publisher","first-page":"H935","DOI":"10.1152\/ajpheart.00708.2005","volume":"290","author":"DL Lee","year":"2006","unstructured":"Lee, D. L. et al. Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am. J. Physiol. Heart Circ. Physiol. 290(3), H935-40 (2006).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"40323_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/HYPERTENSIONAHA.110.158071","volume":"56","author":"MW Brands","year":"2010","unstructured":"Brands, M. W. et al. Interleukin 6 knockout prevents angiotensin II hypertension: Role of renal vasoconstriction and janus kinase 2\/signal transducer and activator of transcription 3 activation. Hypertension 56(5), 879\u201384 (2010).","journal-title":"Hypertension"},{"issue":"1","key":"40323_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1161\/CIRCRESAHA.121.320239","volume":"131","author":"LC Veiras","year":"2022","unstructured":"Veiras, L. C. et al. Tubular IL-1\u03b2 induces salt sensitivity in diabetes by activating renal macrophages. Circ. Res. 131(1), 59\u201373 (2022).","journal-title":"Circ. Res."},{"issue":"10","key":"40323_CR19","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1084\/jem.20070657","volume":"204","author":"TJ Guzik","year":"2007","unstructured":"Guzik, T. J. et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 204(10), 2449\u201360 (2007).","journal-title":"J. Exp. Med."},{"issue":"3","key":"40323_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/jhh.2013.80","volume":"28","author":"S Yoshida","year":"2014","unstructured":"Yoshida, S. et al. Infliximab, a TNF-\u03b1 inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients. J. Hum. Hypertens. 28(3), 165\u20139 (2014).","journal-title":"J. Hum. Hypertens."},{"issue":"3","key":"40323_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.pharmthera.2010.05.002","volume":"127","author":"P Kleinbongard","year":"2010","unstructured":"Kleinbongard, P., Heusch, G. & Schulz, R. TNFalpha in atherosclerosis, myocardial ischemia\/reperfusion and heart failure. Pharmacol. Ther. 127 (3), 295\u2013314 (2010).","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"40323_CR22","first-page":"1085","volume":"151","author":"DB Landry","year":"1997","unstructured":"Landry, D. B. et al. Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. Am. J. Pathol. 151 (4), 1085\u20131095 (1997).","journal-title":"Am. J. Pathol."},{"issue":"2","key":"40323_CR23","doi-asserted-by":"publisher","first-page":"L452","DOI":"10.1152\/ajplung.00378.2002","volume":"286","author":"P Neumann","year":"2004","unstructured":"Neumann, P., Gertzberg, N. & Johnson, A. TNF-alpha induces a decrease in eNOS promoter activity. Am. J. Physiol. Lung Cell. Mol. Physiol. 286 (2), L452\u2013L459 (2004).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"10","key":"40323_CR24","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1128\/MCB.17.10.5719","volume":"17","author":"J Alonso","year":"1997","unstructured":"Alonso, J. et al. Endothelial cytosolic proteins bind to the 3\u2019 untranslated region of endothelial nitric oxide synthase mRNA: Regulation by tumor necrosis factor alpha. Mol. Cell. Biol. 17(10), 5719\u201326 (1997).","journal-title":"Mol. Cell. Biol."},{"key":"40323_CR25","doi-asserted-by":"publisher","first-page":"1098725","DOI":"10.3389\/fimmu.2022.1098725","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets. Front. Immunol. 13, 1098725 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"40323_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.clim.2007.03.546","volume":"124","author":"SF Han","year":"2007","unstructured":"Han, S. F. et al. The opposite-direction modulation of CD4\u2009+\u2009CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clin. Immunol. 124(1), 90\u20137 (2007).","journal-title":"Clin. Immunol."},{"issue":"10","key":"40323_CR27","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00011-012-0510-2","volume":"61","author":"ZD Liu","year":"2012","unstructured":"Liu, Z. D. et al. Increased Th17 cell frequency concomitant with decreased Foxp3\u2009+\u2009Treg cell frequency in the peripheral circulation of patients with carotid artery plaques. Inflamm. Res. 61(10), 1155\u201365 (2012).","journal-title":"Inflamm. Res."},{"issue":"4","key":"40323_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/HJH.0000000000000469","volume":"33","author":"M Katsuki","year":"2015","unstructured":"Katsuki, M. et al. Decreased proportion of Foxp3\u2009+\u2009CD4+ regulatory T cells contributes to the development of hypertension in genetically hypertensive rats. J. Hypertens. 33 (4), 773\u2013783 (2015). discussion 783.","journal-title":"J. Hypertens."},{"issue":"1","key":"40323_CR29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ajpath.2010.11.034","volume":"178","author":"K Matrougui","year":"2011","unstructured":"Matrougui, K. et al. Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice. Am. J. Pathol. 178(1), 434\u201341 (2011).","journal-title":"Am. J. Pathol."},{"issue":"3","key":"40323_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.110.162941","volume":"57","author":"T Barhoumi","year":"2011","unstructured":"Barhoumi, T. et al. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 57 (3), 469\u2013476 (2011).","journal-title":"Hypertension"},{"key":"40323_CR31","doi-asserted-by":"crossref","unstructured":"Majeed, B. et al. Interleukin-2\/Anti-Interleukin-2 Immune Complex Expands Regulatory T Cells and Reduces Angiotensin II-Induced Aortic Stiffening. Int J Hypertens. : p. 126365 (2014). (2014).","DOI":"10.1155\/2014\/126365"},{"issue":"4","key":"40323_CR32","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/HJH.0000000000002328","volume":"38","author":"L Gackowska","year":"2020","unstructured":"Gackowska, L. et al. Regulatory T-cell subset distribution in children with primary hypertension is associated with hypertension severity and hypertensive target organ damage. J. Hypertens. 38(4), 692\u2013700 (2020).","journal-title":"J. Hypertens."},{"issue":"12","key":"40323_CR33","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.2337\/dc07-0629","volume":"30","author":"J Siebert","year":"2007","unstructured":"Siebert, J. et al. Low serum angiogenin concentrations in patients with type 2 diabetes. Diabetes Care. 30 (12), 3086\u20133087 (2007).","journal-title":"Diabetes Care"},{"issue":"1","key":"40323_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28338-0","volume":"13","author":"K Piekarska","year":"2022","unstructured":"Piekarska, K. et al. Mesenchymal stem cells transfer mitochondria to allogeneic Tregs in an HLA-dependent manner improving their immunosuppressive activity. Nat. Commun. 13(1), 856 (2022).","journal-title":"Nat. Commun."},{"issue":"5","key":"40323_CR35","doi-asserted-by":"publisher","first-page":"e0126190","DOI":"10.1371\/journal.pone.0126190","volume":"10","author":"N Marek-Trzonkowska","year":"2015","unstructured":"Marek-Trzonkowska, N. et al. Arterial hypertension is characterized by imbalance of pro-angiogenic versus anti-angiogenic factors. PLoS One 10(5), e0126190 (2015).","journal-title":"PLoS One"},{"issue":"21","key":"40323_CR36","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1097\/00029330-200811010-00012","volume":"121","author":"L Wang","year":"2008","unstructured":"Wang, L. et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model. Chin. Med. J. (Engl.) 121(21), 2167\u201371 (2008).","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"5","key":"40323_CR37","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12644","volume":"21","author":"S Kimura","year":"2021","unstructured":"Kimura, S. et al. Macrophage CCL22 expression promotes lymphangiogenesis in patients with tongue squamous cell carcinoma via IL-4\/STAT6 in the tumor microenvironment. Oncol. Lett. 21(5), 383 (2021).","journal-title":"Oncol. Lett."},{"issue":"5","key":"40323_CR38","doi-asserted-by":"publisher","first-page":"H1685","DOI":"10.1152\/ajpheart.00015.2009","volume":"297","author":"M Onimaru","year":"2009","unstructured":"Onimaru, M. et al. VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B. Am. J. Physiol. Heart Circ. Physiol. 297(5), H1685-96 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"40323_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ni1013","volume":"5","author":"MJ Karkkainen","year":"2004","unstructured":"Karkkainen, M. J. et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5(1), 74\u201380 (2004).","journal-title":"Nat. Immunol."},{"issue":"5","key":"40323_CR40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/emboj.2012.340","volume":"32","author":"R H\u00e4gerling","year":"2013","unstructured":"H\u00e4gerling, R. et al. A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy. EMBO J. 32 (5), 629\u2013644 (2013).","journal-title":"EMBO J."},{"issue":"4","key":"40323_CR41","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.exer.2006.12.013","volume":"84","author":"Z Zheng","year":"2007","unstructured":"Zheng, Z., Chen, H., Xu, X., Li, C. & Gu, Q. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy. Exp. Eye Res. 84(4), 745\u201352 (2007).","journal-title":"Exp. Eye Res."},{"issue":"1","key":"40323_CR42","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","volume":"19","author":"C Lee","year":"2025","unstructured":"Lee, C. et al. Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. Signal. Transduct. Target. Ther. 19 (1), 170 (2025).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"40323_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/jb\/mvs136","volume":"153","author":"M Shibuya","year":"2013","unstructured":"Shibuya, M. Vascular endothelial growth factor and its receptor system: Physiological functions in angiogenesis and pathological roles in various diseases. J. Biochem. 153(1), 13\u201319 (2013).","journal-title":"J. Biochem."},{"issue":"4","key":"40323_CR44","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.str.2015.01.018","volume":"23","author":"MW Parker","year":"2015","unstructured":"Parker, M. W. et al. Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form. Structure 23 (4), 677\u2013687 (2015).","journal-title":"Structure"},{"issue":"7","key":"40323_CR45","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1080\/10739680902997333","volume":"16","author":"J Woolard","year":"2009","unstructured":"Woolard, J., Bevan, H. S., Harper, S. J. & Bates, D. O. Molecular diversity of VEGF-A as a regulator of its biological activity. Microcirculation 16 (7), 572\u2013592 (2009).","journal-title":"Microcirculation"},{"key":"40323_CR46","doi-asserted-by":"crossref","unstructured":"Zorena, K. at al. Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus. J Hum Hypertens. 24(11):755\u2009\u2013\u200962 (2010).","DOI":"10.1038\/jhh.2010.7"},{"key":"40323_CR47","doi-asserted-by":"crossref","unstructured":"Heyman, S. N. et al. Diabetic proteinuria revisited: updated physiologic perspectives. Cells. 11(18):2917 49. Navis, G., Faber,H.J., de Zeeuw, D., & de Jong, P.E. ACE inhibitors and the kidney. A risk-benefit assessment. Drug Saf. 15 (3):pp. 200\u2009\u2013\u200911 (1996). (2022).","DOI":"10.2165\/00002018-199615030-00005"},{"issue":"22","key":"40323_CR48","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15094","volume":"9","author":"G Baranwal","year":"2021","unstructured":"Baranwal, G. et al. Expanded renal lymphatics improve recovery following kidney injury. Physiol. Rep. 9(22), e15094 (2021).","journal-title":"Physiol. Rep."},{"issue":"2","key":"40323_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/biom10020289","volume":"10","author":"MJA Schoonderwoerd","year":"2020","unstructured":"Schoonderwoerd, M. J. A., Goumans, M. T. H. & Hawinkels, L. J. A. C. Endoglin: Beyond the endothelium. Biomolecules 10(2), 289 (2020).","journal-title":"Biomolecules"},{"issue":"7","key":"40323_CR50","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/intimm\/dxh272","volume":"17","author":"CB Schmidt-Weber","year":"2005","unstructured":"Schmidt-Weber, C. B. et al. TGF-{beta} signaling of human T cells is modulated by the ancillary TGF-{beta} receptor endoglin. Int. Immunol. 17(7), 921\u201330 (2005).","journal-title":"Int. Immunol."},{"key":"40323_CR51","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.atherosclerosis.2007.04.022","volume":"197","author":"M Blaha","year":"2008","unstructured":"Blaha, M. et al. Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia. Atherosclerosis 197, 264\u2013270 (2008).","journal-title":"Atherosclerosis"},{"issue":"4","key":"40323_CR52","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.119.13348","volume":"74","author":"A Lea\u00f1os-Miranda","year":"2019","unstructured":"Lea\u00f1os-Miranda, A. et al. Soluble endoglin as a marker for preeclampsia, its severity, and the occurrence of adverse outcomes. Hypertension 74 (4), 991\u2013997 (2019).","journal-title":"Hypertension"},{"issue":"1","key":"40323_CR53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.atherosclerosis.2012.03.001","volume":"224","author":"P Nachtigal","year":"2012","unstructured":"Nachtigal, P., Zemankova Vecerova, L., Rathouska, J. & Strasky, Z. The role of endoglin in atherosclerosis. Atherosclerosis 224 (1), 4\u201311 (2012).","journal-title":"Atherosclerosis"},{"issue":"3","key":"40323_CR54","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4274\/jcrpe.2906","volume":"8","author":"HC Emeksiz","year":"2016","unstructured":"Emeksiz, H. C. et al. Soluble endoglin level increase occurs prior to development of subclinical structural vascular alterations in diabetic adolescents. J. Clin. Res. Pediatr. Endocrinol. 8(3), 313\u201320 (2016).","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"40323_CR55","first-page":"216","volume":"49","author":"LK Hill","year":"2013","unstructured":"Hill, L. K., Iii, S., Thayer, J. F. & J.J. & Resistance reconstructed Estimation of total peripheral resistance from computationally derived cardiac output - biomed 2013. Biomed. Sci. Instrum. 49, 216\u2013223 (2013).","journal-title":"Biomed. Sci. Instrum."},{"issue":"Pt 1","key":"40323_CR56","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1469-7793.2000.t01-1-00263.x","volume":"525","author":"IB Wilkinson","year":"2000","unstructured":"Wilkinson, I. B. et al. The influence of heart rate on augmentation index and central arterial pressure in humans. J. Physiol. 525 (Pt 1), 263\u2013270 (2000).","journal-title":"J. Physiol."},{"issue":"8","key":"40323_CR57","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/jhh.2011.59","volume":"26","author":"JH Janner","year":"2012","unstructured":"Janner, J. H. et al. The association between aortic augmentation index and cardiovascular risk factors in a large unselected population. J. Hum. Hypertens. 26(8), 476\u201384 (2012).","journal-title":"J. Hum. Hypertens."},{"key":"40323_CR58","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.carrev.2024.05.020","volume":"69","author":"I Merdler","year":"2024","unstructured":"Merdler, I. et al. Coronary microvascular dysfunction and inflammation: Insights from the Coronary Microvascular Disease Registry. Cardiovasc. Revasc. Med. 69, 30\u201334 (2024).","journal-title":"Cardiovasc. Revasc. Med."},{"issue":"5","key":"40323_CR59","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00109-022-02193-4","volume":"100","author":"AJ Salminen","year":"2022","unstructured":"Salminen, A. J. Clinical perspectives on the age-related increase of immunosuppressive activity. Mol. Med. (Berl). 100 (5), 697\u2013712 (2022).","journal-title":"Mol. Med. (Berl)"},{"key":"40323_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.584538","volume":"12","author":"M Delgobo","year":"2021","unstructured":"Delgobo, M. et al. Terminally differentiated CD4+ T cells promote myocardial inflammaging. Front. Immunol. 12, 584538 (2021).","journal-title":"Front. Immunol."},{"issue":"2","key":"40323_CR61","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1053\/j.gastro.2008.09.064","volume":"136","author":"F Scaldaferri","year":"2009","unstructured":"Scaldaferri, F. et al. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology 136(2), 585\u201395.e5 (2009).","journal-title":"Gastroenterology"},{"key":"40323_CR62","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.935135","volume":"28","author":"J Dziedziak","year":"2022","unstructured":"Dziedziak, J. et al. Impact of arterial hypertension on the eye: A review of the pathogenesis, diagnostic methods, and treatment of hypertensive retinopathy. Med. Sci. Monit. 28, e935135 (2022).","journal-title":"Med. Sci. Monit."},{"issue":"6","key":"40323_CR63","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/ICU.0000000000000307","volume":"27","author":"L Konstantinidis","year":"2016","unstructured":"Konstantinidis, L. & Guex-Crosier, Y. Hypertension and the eye. Curr. Opin. Ophthalmol. 27 (6), 514\u2013521 (2016).","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"11","key":"40323_CR64","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1182\/blood.V112.11.5473.5473","volume":"112","author":"G Corinaldesi","year":"2008","unstructured":"Corinaldesi, G. & Corinaldesi, C. A reliable marker of endothelial cell dysfunction and vascular damage: Legend or reality?. Blood 112(11), 5473 (2008).","journal-title":"Blood"},{"issue":"1","key":"40323_CR65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10456-021-09799-1","volume":"25","author":"JCF Quintanilha","year":"2022","unstructured":"Quintanilha, J. C. F. et al. Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance). Angiogenesis 25(1), 47\u201355 (2022).","journal-title":"Angiogenesis"},{"key":"40323_CR66","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0002-9149(00)01512-5","volume":"87","author":"FM Belgore","year":"2001","unstructured":"Belgore, F. M., Blann, A. D., Li-Saw-Hee, F. L., Beevers, D. G. & Lip, G. Y. H. Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension. Am. J. Cardiol. 87, 805\u2013807 (2001).","journal-title":"Am. J. Cardiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40323-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40323-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40323-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:02:37Z","timestamp":1776146557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40323-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40323"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40323-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12270"}}